Landing Aquaculture partners with Nofima AS for an experimental RAS facility

20 experimental RAS will study the performance of Atlantic salmon under intensive culture conditions.  

Landing Aquaculture partners with Nofima AS for an experimental RAS facility
July 5, 2021

Landing Aquaculture and Nofima signed a contract for the supply of 20 fully automated RAS systems. The systems will be installed at Nofima’s research center in Sunndalsøra, Norway. It is planned to be delivered and operational by October 2021. 

Each experimental RAS unit is designed to hold up to 60kg/m3 fish under very strict water quality standards including a maximal dissolved CO2 concentration of 10 mg/L. Every unit has a 60-micron drum filter unit, two-stage MBBR, full-flow degassing, low head oxygen cone and a temperature control system. Water quality and flow will be constantly monitored and controlled by oxygen, pH, temperature, water level and water flow sensors. The fish tanks can be operated as single drain tanks or Cornell dual drain tanks at varying water levels. This flexibility allows for trials with salmon in a variety of life stages.    

For Landing Aquaculture BV, this will be one of the biggest RAS supply contracts so far. Co-founder and managing director, Rob van de Ven, looks forward to the challenge ahead, as it is the next step forward for the company. “This project will show that Landing Aquaculture not only has a strong engineering foundation but that it has also matured as a company with manufacturing capabilities to handle turn-key projects of this size.”

Co-founder and innovation director, Carlos Espinal, sees this as the perfect opportunity to show how the RAS technology has matured over the last decade. “We take pride in working at the cutting edge of RAS. To do this, it is essential to remain both creative and technically correct. This project showcases how design can meet operational demands if your engineering knowledge is robust.”

Landing has worked with salmonids, percids, crustaceans, tropical and marine species. As innovator, The company holds the patent for a bloodwater treatment unit and is a partner of the easyTRAIN industrial PhD program under H2020/Marie Skłodowska-Curie Actions.